Routine high-dose supplementation is not a substitute for diagnosis
(See Adverse effects .) Adverse effects Potential adverse effects of semaglutide and their underlying mechanisms include the following: Acute kidney injury The exact mechanism for this adverse effect is unknown
Liraglutide has advantages, like the ability to adjust the dose using the same pen
From Bench to Bedside: Clinical Evidence Supporting GLP-1 Therapy The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants that relate to GLP-1 and related signaling pathways
In 2023, an estimated 13.3 million Medicare beneficiaries enrolled in Parts A and B had obesity or overweight, based on having BMI of 27 or more recorded in claims or encounter data, or 24% of Medicare beneficiaries overall (Figure 1)
Conversely, some individuals who initially tolerated high doses find that after substantial weight loss, lower doses provide adequate maintenance with fewer side effects